Activation of SIRT1/Nrf2/GPx4 signaling following Res treatment represents a potential therapeutic strategy for inhibiting ferroptosis and ameliorating HIBI‐induced learning and memory impairments. The gene discussed is SIRT1; the disease is memory impairment.